TORONTO — Cannabis company Flora Growth Corp. has entered into an agreement to acquire CBD brand Masaya and its patent-pending CBD formulations.
Masaya’s CBD oil formulations are 100% THC-free, and Flora intends to distribute the brand worldwide. Annabelle Manalo-Morgan, a scientist, educator, author and mother, created Masaya for her son, who suffered from seizures and found relief with CBD.
“This acquisition allows us to deliver on our promise to invest in safe, thorough, cutting-edge scientific research that can bring meaningful change via an efficacious and accessible product offering for people worldwide,” Flora’s Chairman and CEO Luis Merchan said.
As a member of Flora’s board of directors and as the company’s scientific advisor, Manalo-Morgan is responsible for leading Flora’s global research initiatives, including its ongoing clinical trial on the use of cannabinoids with patients who have fibromyalgia in partnership with the University of Manchester in the United Kingdom.
“Both consumers and the global scientific community deserve more research and data on the science behind CBD, and I feel truly grateful to be working with the Flora team to help develop some of the highest-quality, scientifically vetted products in the world,” Manalo-Morgan said.
Toronto-based Flora Growth Corp. is a plant-based wellness and lifestyle brand. It acquired Miami-based JustCBD, which sells CBD gummies, relief creams and more, in March.
Masaya Medical LLC is based in Franklin, Tenn.
Members help make our journalism possible. Become a CSP member today and unlock exclusive benefits, including unlimited access to all of our content. Sign up here.
Exclusive Content
Leading the Charge
Ethanol and EVs stand at the head of the pack of alternative-fuel retail strategies
PDI Report Gives Tips on Growing C-Store Trips, Basket Size
While convenience channel sees in-store sales growth, most is driven by inflation